Macular Edema Archives - MPR

Macular Edema

FDA Accepts BLA for Abicipar Pegol for Neovascular Age-Related Macular Degeneration

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for abicipar pegol (Allergan), an investigational DARPin (designed ankyrin repeat proteins) therapy, in patients with neovascular (wet) age-related macular degeneration (nAMD). Abicipar pegol is comprised of DARPin molecules, which are part of a new investigational class of binding protein. It works by…